44
Participants
Start Date
August 31, 2007
Primary Completion Date
June 30, 2010
Study Completion Date
June 30, 2010
DOS (Docetaxel, Oxaliplatin and S-1)
Docetaxel 52.5mg/m2 IV on D1 (diluted in 250 ml of normal saline over a 1 hour of each cycle before oxaliplatin) Oxaliplatin 105mg/m2 IV on D1 (diluted in 250 ml of 5% DW for 2 hours) S-1 80mg/m2/day on D1-14 (2 weeks of treatment followed by a 1-week rest period)
Hallym University Medical Center, Anyang
Asan Medical Center, Seoul
Collaborators (2)
Asan Medical Center
OTHER
Sanofi
INDUSTRY
Hallym University Medical Center
OTHER